)
Precigen (PGEN) investor relations material
Precigen Fireside chat summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Introduction and agenda
Discussion focused on the commercial launch and clinical impact of Papzimeos, the first immunotherapy for adult RRP, following its FDA approval in 2025.
Speakers included the CEO and CCO, covering clinical, commercial, and strategic aspects.
Background and experience of the speaker
CEO has extensive experience in developing therapies, emphasizing innovation in viral vector platforms.
CCO detailed the commercial strategy and operational execution for the launch.
Current industry trends
Shift toward immunotherapies and personalized medicine for rare diseases.
Growing importance of platform technologies for rapid development and regulatory efficiency.
- PAPZIMEOS launch accelerates revenue growth and adoption, with Q1 2026 revenue set to exceed $18M.PGEN
Q4 202525 Mar 2026 - PAPZIMEOS launch accelerates adoption and revenue, but non-cash charges drive Q3 net loss.PGEN
Q3 20253 Feb 2026 - PRGN-2012 pivotal data and focus drive new funding, but losses and going concern risks persist.PGEN
Q2 20241 Feb 2026 - 51% complete response and 86% surgery reduction with durable benefit and strong safety.PGEN
Study Result31 Jan 2026 - FDA-approved RRP therapy saw rapid US uptake, strong brand growth, and global expansion plans.PGEN
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Gene therapy for RRP shows strong efficacy, safety, and commercial promise, with BLA submission imminent.PGEN
Stifel 2024 Healthcare Conference13 Jan 2026 - Gene therapy for RRP nears FDA approval, with UltraCAR-T and global expansion advancing.PGEN
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - PRGN-2012 nears FDA approval with strong efficacy and funding extends operations into 2026.PGEN
Q4 202426 Dec 2025 - Large resale registration may dilute shareholders as the company advances gene therapy assets.PGEN
Registration Filing16 Dec 2025
Next Precigen earnings date
Next Precigen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)